Log in

NYSE:GLGlobe Life Stock Price, Forecast & News

+1.39 (+1.92 %)
(As of 07/7/2020 04:00 PM ET)
Today's Range
Now: $73.92
50-Day Range
MA: $76.13
52-Week Range
Now: $73.92
Volume537,500 shs
Average Volume594,243 shs
Market Capitalization$7.87 billion
P/E Ratio11.03
Dividend Yield1.01%
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers term life, whole life, children's life, senior life, and family life insurance products; accidental benefits insurance; mortgage protection insurance; and medicare supplement plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. is based in McKinney, Texas.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.8Community Rank: 1.6Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars

Industry, Sector and Symbol

Industry Life insurance



Sales & Book Value

Annual Sales$4.53 billion
Cash Flow$12.04 per share
Book Value$67.36 per share


Net Income$760.79 million


Market Cap$7.87 billion
Next Earnings Date7/22/2020 (Estimated)

Receive GL News and Ratings via Email

Sign-up to receive the latest news and ratings for GL and its competitors with MarketBeat's FREE daily newsletter.

Globe Life (NYSE:GL) Frequently Asked Questions

How has Globe Life's stock been impacted by COVID-19 (Coronavirus)?

Globe Life's stock was trading at $73.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GL shares have increased by 0.7% and is now trading at $73.92. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Globe Life?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globe Life in the last year. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Globe Life.

When is Globe Life's next earnings date?

Globe Life is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Globe Life.

How were Globe Life's earnings last quarter?

Globe Life Inc. (NYSE:GL) announced its earnings results on Wednesday, April, 22nd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.01. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.17 billion. Globe Life had a return on equity of 10.86% and a net margin of 16.32%. The company's revenue was up 1.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.64 earnings per share. View Globe Life's earnings history.

How often does Globe Life pay dividends? What is the dividend yield for Globe Life?

Globe Life declared a quarterly dividend on Friday, May 15th. Shareholders of record on Monday, July 6th will be given a dividend of $0.1875 per share on Friday, July 31st. This represents a $0.75 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Thursday, July 2nd. View Globe Life's dividend history.

What guidance has Globe Life issued on next quarter's earnings?

Globe Life issued an update on its FY20 earnings guidance on Wednesday, April, 22nd. The company provided earnings per share (EPS) guidance of $6.65-7.15 for the period, compared to the Thomson Reuters consensus estimate of $7.05.

What price target have analysts set for GL?

6 brokerages have issued twelve-month price targets for Globe Life's stock. Their forecasts range from $77.00 to $114.00. On average, they anticipate Globe Life's stock price to reach $86.00 in the next year. This suggests a possible upside of 16.3% from the stock's current price. View analysts' price targets for Globe Life.

Has Globe Life been receiving favorable news coverage?

News stories about GL stock have trended negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Globe Life earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Globe Life.

Are investors shorting Globe Life?

Globe Life saw a drop in short interest in June. As of June 30th, there was short interest totaling 1,630,000 shares, a drop of 9.9% from the June 15th total of 1,810,000 shares. Based on an average trading volume of 703,400 shares, the days-to-cover ratio is presently 2.3 days. Approximately 1.6% of the shares of the stock are sold short. View Globe Life's Current Options Chain.

Who are some of Globe Life's key competitors?

What other stocks do shareholders of Globe Life own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globe Life investors own include Occidental Petroleum (OXY), Verizon Communications (VZ), Gilead Sciences (GILD), IBM (IBM), Marathon Petroleum (MPC), AT&T (T), AbbVie (ABBV), Costco Wholesale (COST), Cisco Systems (CSCO) and Dominion Energy (D).

Who are Globe Life's key executives?

Globe Life's management team includes the following people:
  • Mr. Gary Lee Coleman, Co-Chairman & CEO (Age 66)
  • Mr. Larry Mac Hutchison, Co-Chairman & CEO (Age 65)
  • Mr. Frank Martin Svoboda, Exec. VP & CFO (Age 57)
  • Mr. W. Michael Pressley, Exec. VP & Chief Investment Officer (Age 67)
  • Mr. James Matthew Darden, Exec. VP & Chief Strategy Officer (Age 48)

What is Globe Life's stock symbol?

Globe Life trades on the New York Stock Exchange (NYSE) under the ticker symbol "GL."

Who are Globe Life's major shareholders?

Globe Life's stock is owned by a number of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.07%) and Municipal Employees Retirement System of Michigan (0.02%). Company insiders that own Globe Life stock include Bill Leavell, Carol A Mccoy, Charles E Adair, Darren M Rebelez, David Kendall Carlson, David L Boren, Frank M Svoboda, Gary L Coleman, James Matthew Darden, John Henry Rogers Jr, Larry M Hutchison, Michael Shane Henrie, Steven John Dichiaro and Vern D Herbel. View institutional ownership trends for Globe Life.

Which institutional investors are buying Globe Life stock?

GL stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Municipal Employees Retirement System of Michigan. View insider buying and selling activity for Globe Life.

How do I buy shares of Globe Life?

Shares of GL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Globe Life's stock price today?

One share of GL stock can currently be purchased for approximately $73.92.

How big of a company is Globe Life?

Globe Life has a market capitalization of $7.87 billion and generates $4.53 billion in revenue each year. The company earns $760.79 million in net income (profit) each year or $6.75 on an earnings per share basis. Globe Life employs 3,196 workers across the globe.

What is Globe Life's official website?

The official website for Globe Life is www.globelifeinsurance.com.

How can I contact Globe Life?

Globe Life's mailing address is 3700 South Stonebridge Drive, McKinney TX, 75070. The company can be reached via phone at 972-569-4000 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.